Intrahost Genome Alterations in Enterohemorrhagic Escherichia coli

Gastroenterology

Volumn 136, Issue 6, 2009, Pages 1925-1938

  Mellmann, Alexander ^a   Bielaszewska, Martina ^a   Karch, Helge ^a  

^a National Consulting Laboratory on Hemolytic Uremic Syndrome   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; SHIGA TOXIN;

ADAPTATION; ARTICLE; BACTERIAL CELL; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOODY DIARRHEA; CAMPYLOBACTER JEJUNI; CHROMOSOMAL INSTABILITY; CHROMOSOME; CHROMOSOME STRUCTURE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROINVASIVE ESCHERICHIA COLI; EVOLUTION; FECES ANALYSIS; GENE DELETION; GENE DUPLICATION; GENE FUNCTION; GENE SEQUENCE; GENE TRANSFER; GENOMIC ISLAND; HELICOBACTER PYLORI; HUMAN; INTEGRON; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; SALMONELLA ENTERICA; SHIGELLA; TRANSPOSON; VIBRIO CHOLERAE; VIBRIO PARAHAEMOLYTICUS; VIRULENCE; YERSINIA;

EID: 65449147848     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.12.072     Document Type: Article

References (132)

1. Perna N.T., Plunkett G., Burland V., et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409 (2001) 529-533
2. Hayashi T., Makino K., Ohnishi M., et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 8 (2001) 11-22
3. Hacker J., and Carniel E. Ecological fitness, genomic islands and bacterial pathogenicity. A Darwinian view of the evolution of microbes. EMBO Rep 2 (2001) 376-381
4. Trucksis M., Michalski J., Deng Y.K., et al. The Vibrio cholerae genome contains two unique circular chromosomes. Proc Natl Acad Sci U S A 95 (1998) 14464-14469
5. Heidelberg J.F., Eisen J.A., Nelson W.C., et al. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406 (2000) 477-483
6. Dobrindt U., Hochhut B., Hentschel U., et al. Genomic islands in pathogenic and environmental microorganisms. Nat Rev Microbiol 2 (2004) 414-424
7. Mellies J.L., Elliott S.J., Sperandio V., et al. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol 33 (1999) 296-306
8. Baker S., Holt K., Whitehead S., et al. A linear plasmid truncation induces unidirectional flagellar phase change in H:z66 positive Salmonella Typhi. Mol Microbiol 66 (2007) 1207-1218
9. Baker S., Hardy J., Sanderson K.E., et al. A novel linear plasmid mediates flagellar variation in Salmonella Typhi. PLoS Pathog 3 (2007) e59
10. Mazel D. Integrons: agents of bacterial evolution. Nat Rev Microbiol 4 (2006) 608-620
11. Bielaszewska M., Dobrindt U., Gartner J., et al. Aspects of genome plasticity in pathogenic Escherichia coli. Int J Med Microbiol 297 (2007) 625-639
12. Sokurenko E.V., Gomulkiewicz R., and Dykhuizen D.E. Source-sink dynamics of virulence evolution. Nat Rev Microbiol 4 (2006) 548-555
13. Mwangi M.M., Wu S.W., Zhou Y., et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A 104 (2007) 9451-9456
14. Turner A.K., Nair S., and Wain J. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother 58 (2006) 733-740
15. Hopkins K.L., Davies R.H., and Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25 (2005) 358-373
16. Wang Y., Huang W.M., and Taylor D.E. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob Agents Chemother 37 (1993) 457-463
17. Luo N., Pereira S., Sahin O., et al. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci USA 102 (2005) 541-546
18. Björkman J., Nagaev I., Berg O.G., et al. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287 (2000) 1479-1482
19. Brockmeyer J., Bielaszewska M., Fruth A., et al. Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity. Appl Environ Microbiol 73 (2007) 6351-6359
20. Khan A.B., Naim A., Orth D., et al. Serine protease espP subtype alpha, but not beta or gamma, of Shiga toxin-producing Escherichia coli is associated with highly pathogenic serogroups. Int J Med Microbiol (2008) doi:10.1016/j.ijmm.2008.08.006
21. Giraud A., Arous S., De Paepe M., et al. Dissecting the genetic components of adaptation of Escherichia coli to the mouse gut. PLoS Genet 4 (2008) e2
22. Bielaszewska M., Prager R., Zhang W., et al. Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol 72 (2006) 1900-1909
23. Muniesa M., de Simon M., Prats G., et al. Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak. Infect Immun 71 (2003) 4554-4562
24. Villa L., and Carattoli A. Integrons and transposons on the Salmonella enterica serovar typhimurium virulence plasmid. Antimicrob Agents Chemother 49 (2005) 1194-1197
25. Holt K.E., Parkhill J., Mazzoni C.J., et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet 40 (2008) 987-993
26. Maurelli A.T., Fernandez R.E., Bloch C.A., et al. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc Natl Acad Sci U S A 95 (1998) 3943-3948
27. McCormick B.A., Fernandez M.I., Siber A.M., et al. Inhibition of Shigella flexneri-induced transepithelial migration of polymorphonuclear leucocytes by cadaverine. Cell Microbiol 1 (1999) 143-155
28. Torres A.G., Vazquez-Juarez R.C., Tutt C.B., et al. Pathoadaptive mutation that mediates adherence of Shiga toxin-producing Escherichia coli O111. Infect Immun 73 (2005) 4766-4776
29. Zhang W., Mellmann A., Sonntag A., et al. Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. Int J Med Microbiol 297 (2007) 17-26
30. Levine M.M., Nataro J.P., Karch H., et al. The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis 152 (1985) 550-559
31. Goerke C., Matias Y., Papenberg S., et al. Increased frequency of genomic alterations in Staphylococcus aureus during chronic infection is in part due to phage mobilization. J Infect Dis 189 (2004) 724-734
32. Mathee K., Narasimhan G., Valdes C., et al. Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A 105 (2008) 3100-3105
33. Linz B., Balloux F., Moodley Y., et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445 (2007) 915-918
34. Gressmann H., Linz B., Ghai R., et al. Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet 1 (2005) e43
35. Suerbaum S., and Josenhans C. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat Rev Microbiol 5 (2007) 441-452
36. Falush D., Kraft C., Taylor N.S., et al. Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc Natl Acad Sci U S A 98 (2001) 15056-15061
37. Kraft C., Stack A., Josenhans C., et al. Genomic changes during chronic Helicobacter pylori infection. J Bacteriol 188 (2006) 249-254
38. Oh J.D., Kling-Backhed H., Giannakis M., et al. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc Natl Acad Sci U S A 103 (2006) 9999-10004
39. Olesen B., Kolmos H.J., Orskov F., et al. Escherichia coli bacteraemia in patients with and without haematological malignancies: a study of strain characters and recurrent episodes. J Infect 36 (1998) 93-100
40. Zdziarski J., Svanborg C., Wullt B., et al. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?. Infect Immun 76 (2008) 695-703
41. Rosen D.A., Hooton T.M., Stamm W.E., et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4 (2007) e329
42. Levine M.M., Xu J.G., Kaper J.B., et al. A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 156 (1987) 175-182
43. Tarr P.I., Gordon C.A., and Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365 (2005) 1073-1086
44. Karch H., Tarr P.I., and Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295 (2005) 405-418
45. Banatvala N., Griffin P.M., Greene K.D., et al. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183 (2001) 1063-1070
46. Friedrich A.W., Bielaszewska M., Zhang W., et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185 (2002) 74-84
47. Gerber A., Karch H., Allerberger F., et al. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 186 (2002) 493-500
48. Lynn R.M., O'Brien S.J., Taylor C.M., et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 11 (2005) 590-596
49. Bell B.P., Goldoft M., Griffin P.M., et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 272 (1994) 1349-1353
50. Tarr P.I., Neill M.A., Clausen C.R., et al. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 162 (1990) 553-556
51. Bell B.P., Griffin P.M., Lozano P., et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100 (1997) E12
52. Wong C.S., Jelacic S., Habeeb R.L., et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342 (2000) 1930-1936
53. Caprioli A., Morabito S., Brugere H., et al. Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res 36 (2005) 289-311
54. Frank C., Kapfhammer S., Werber D., et al. Cattle density and Shiga toxin-producing Escherichia coli infection in Germany: increased risk for most but not all serogroups. Vector Borne Zoonotic Dis 8 (2008) 635-643
55. Riley L.W., Remis R.S., Helgerson S.D., et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308 (1983) 681-685
56. Hilborn E.D., Mermin J.H., Mshar P.A., et al. A multistate outbreak of Escherichia coli O157:H7 infections associated with consumption of mesclun lettuce. Arch Intern Med 159 (1999) 1758-1764
57. CDC. Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach-United States, September 2006. MMWR Morb Mortal Wkly Rep 55 (2006) 1045-1046
58. Michino H., Araki K., Minami S., et al. Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol 150 (1999) 787-796
59. Kaper J.B., and Karmali M.A. The continuing evolution of a bacterial pathogen. Proc Natl Acad Sci U S A 105 (2008) 4535-4536
60. Holme R. Drinking water contamination in Walkerton, Ontario: positive resolutions from a tragic event. Water Sci Technol 47 (2003) 1-6
61. Crump J.A., Sulka A.C., Langer A.J., et al. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N Engl J Med 347 (2002) 555-560
62. Werber D., Mason B.W., Evans M.R., et al. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis 46 (2008) 1189-1196
63. Ammon A., Petersen L.R., and Karch H. A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H-. J Infect Dis 179 (1999) 1274-1277
64. Rosser T., Dransfield T., Allison L., et al. Pathogenic potential of emergent sorbitol-fermenting Escherichia coli O157:NM. Infect Immun 76 (2008) 5598-5607
65. Alpers K., Werber D., Frank C., et al. Sorbitol-fermenting enterohaemorrhagic Escherichia coli O157:H- causing another outbreak of haemolytic ureamic syndrome among children in Germany. Epidemiol Infect 137 (2009) 389-395
66. Orth D., Grif K., Dierich M.P., et al. Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157: indications for an animal reservoir. Epidemiol Infect 134 (2006) 719-723
67. Denno D.M., Klein E.J., Young V.B., et al. Explaining unexplained diarrhea and associating risks and infections. Anim Health Res Rev 8 (2007) 69-80
68. Werber D., Behnke S.C., Fruth A., et al. Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol 165 (2007) 425-434
69. Sandvig K. Shiga toxins. Toxicon 39 (2001) 1629-1635
70. Bielaszewska M., and Karch H. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb Haemost 94 (2005) 312-318
71. Karch H., Böhm H., Schmidt H., et al. Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol 31 (1993) 1200-1205
72. Bielaszewska M., Zhang W., Tarr P.I., et al. Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J Clin Microbiol 43 (2005) 4225-4228
73. Beutin L., Krause G., Zimmermann S., et al. Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 42 (2004) 1099-1108
74. Sonntag A., Prager R., Bielaszewska M., et al. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J Clin Microbiol 42 (2004) 954-962
75. Mellmann A., Bielaszewska M., Zimmerhackl L.B., et al. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis 41 (2005) 785-792
76. Johnson K.E., Thorpe C.M., and Sears C.L. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 43 (2006) 1587-1595
77. Brooks J.T., Bergmire-Sweat D., Kennedy M., et al. Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp. Clin Infect Dis 38 (2004) 190-198
78. Eklund M., Bielaszewska M., Nakari U., et al. Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H- human isolates from Finland. Clin Microbiol Infect 12 (2006) 634-641
79. Karmali M.A., Petric M., Lim C., et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151 (1985) 775-782
80. Schimmer B., Nygard K., Eriksen H., et al. Outbreak of haemolytic uraemic syndrome in Norway caused by stx2 positive Escherichia coli O103:H25 traced to cured mutton sausages. BMC Infect Dis 8 (2008) 41
81. Jelacic J.K., Damrow T., Chen G.S., et al. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 188 (2003) 719-729
82. Bielaszewska M., Friedrich A.W., Aldick T., et al. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 43 (2006) 1160-1167
83. Boerlin P., McEwen S.A., Boerlin-Petzold F., et al. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37 (1999) 497-503
84. Jerse A.E., Yu J., Tall B.D., et al. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87 (1990) 7839-7843
85. Bielaszewska M., Middendorf B., Kock R., et al. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin Infect Dis 47 (2008) 208-217
86. Bielaszewska M., Köck R., Friedrich A., et al. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?. PLoS ONE 2 (2007) e1024
87. Bokete T.N., O'Callahan C.M., Clausen C.R., et al. Shiga-like toxin-producing Escherichia coli in Seattle children: a prospective study. Gastroenterology 105 (1993) 1724-1731
88. Bokete T.N., Whittam T.S., Wilson R.A., et al. Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children. J Infect Dis 175 (1997) 1382-1389
89. Friedrich A.W., Zhang W., Bielaszewska M., et al. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 45 (2007) 39-45
90. Mellmann A., Lu S., Karch H., et al. Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol 74 (2008) 67-72
91. Bielaszewska M., Prager R., Köck R., et al. Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol 73 (2007) 3144-3150
92. Kaper J.B., Nataro J.P., and Mobley H.L. Pathogenic Escherichia coli. Nat Rev Microbiol 2 (2004) 123-140
93. Nguyen R.N., Taylor L.S., Tauschek M., et al. Atypical enteropathogenic Escherichia coli infection and prolonged diarrhea in children. Emerg Infect Dis 12 (2006) 597-603
94. Karch H., Rüssmann H., Schmidt H., et al. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol 33 (1995) 1602-1605
95. Tarr P.I., Neill M.A., Clausen C.R., et al. Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987. J Infect Dis 159 (1989) 344-347
96. O'Brien A.D., Newland J.W., Miller S.F., et al. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 226 (1984) 694-696
97. O'Brien A.O., Lively T.A., Chen M.E., et al. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1 (1983) 702
98. Smith H.W., Green P., and Parsell Z. Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol 129 (1983) 3121-3137
99. Wagner P.L., and Waldor M.K. Bacteriophage control of bacterial virulence. Infect Immun 70 (2002) 3985-3993
100. Besser T.E., Shaikh N., Holt N.J., et al. Greater diversity of Shiga toxin-encoding bacteriophage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from humans. Appl Environ Microbiol 73 (2007) 671-679
101. Shaikh N., and Tarr P.I. Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications. J Bacteriol 185 (2003) 3596-3605
102. Brussow H., Canchaya C., and Hardt W. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68 (2004) 560-602
103. Creuzburg K., Kohler B., Hempel H., et al. Genetic structure and chromosomal integration site of the cryptic prophage CP-1639 encoding Shiga toxin 1. Microbiology 151 (2005) 941-950
104. Koch C., Hertwig S., and Appel B. Nucleotide sequence of the integration site of the temperate bacteriophage 6220, which carries the Shiga toxin gene stx(1ox3). J Bacteriol 185 (2003) 6463-6466
105. Karch H., Schmidt H., Janetzki-Mittmann C., et al. Shiga toxins even when different are encoded at identical positions in the genomes of related temperate bacteriophages. Mol Gen Genet 262 (1999) 600-607
106. Neely M.N., and Friedman D.I. Arrangement and functional identification of genes in the regulatory region of lambdoid phage H-19B, a carrier of a Shiga-like toxin. Gene 223 (1998) 105-113
107. Karch H., Strockbine N.A., and O'Brien A.D. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay. FEMS Microbiol Lett 35 (1986) 141-145
108. Kimmitt P.T., Harwood C.R., and Barer M.R. Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis 6 (2000) 458-465
109. Hull A.E., Acheson D.W., Echeverria P., et al. Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: comparison with DNA probes. J Clin Microbiol 31 (1993) 1167-1172
110. Wagner P.L., Acheson D.W., and Waldor M.K. Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect Immun 69 (2001) 1934-1937
111. Barksdale L., and Arden S.B. Persisting bacteriophage infections, lysogeny, and phage conversions. Annu Rev Microbiol 28 (1974) 265-299
112. Murphy K.C., Ritchie J.M., Waldor M.K., et al. Dam methyltransferase is required for stable lysogeny of the Shiga toxin (Stx2)-encoding bacteriophage 933W of enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 190 (2008) 438-441
113. Acheson D.W., Reidl J., Zhang X., et al. In vivo transduction with Shiga toxin 1-encoding phage. Infect Immun 66 (1998) 4496-4498
114. Cornick N.A., Helgerson A.F., Mai V., et al. In vivo transduction of an Stx-encoding phage in ruminants. Appl Environ Microbiol 72 (2006) 5086-5088
115. Toth I., Schmidt H., Dow M., et al. Transduction of porcine enteropathogenic Escherichia coli with a derivative of a shiga toxin 2-encoding bacteriophage in a porcine ligated ileal loop system. Appl Environ Microbiol 69 (2003) 7242-7247
116. Lee J.H., and Choi S. Isolation and characteristics of sorbitol-fermenting Escherichia coli O157 strains from cattle. Microbes Infect 8 (2006) 2021-2026
117. Steinberg K.M., and Levin B.R. Grazing protozoa and the evolution of the Escherichia coli O157:H7 Shiga toxin-encoding prophage. Proc Biol Sci 274 (2007) 1921-1929
118. Agin T.S., Zhu C., Johnson L.A., et al. Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin. Infect Immun 73 (2005) 6608-6619
119. Zhang W.L., Bielaszewska M., Liesegang A., et al. Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. J Clin Microbiol 38 (2000) 2134-2140
120. Iguchi A., Thomson N.R., Ogura Y., et al. The complete genome sequence and comparative genome analysis of enteropathogenic E. coli O127:H6 strain E2348/69. J Bacteriol 191 (2009) 347-354
121. Mellmann A., Bielaszewska M., Köck R., et al. Serotypes and phylogenetic analysis of the collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli (HUSEC). Emerg Infect Dis 12 (2008) 1287-1290
122. Feil E.J., Li B.C., Aanensen D.M., et al. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186 (2004) 1518-1530
123. Parkhill J., Wren B.W., Mungall K., et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403 (2000) 665-668
124. Sebaihia M., Wren B.W., Mullany P., et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38 (2006) 779-786
125. Tomb J.F., White O., Kerlavage A.R., et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 (1997) 539-547
126. Thomson N.R., Clayton D.J., Windhorst D., et al. Comparative genome analysis of Salmonella Enteritidis PT4 and Salmonella Gallinarum 287/91 provides insights into evolutionary and host adaptation pathways. Genome Res 18 (2008) 1624-1637
127. Parkhill J., Dougan G., James K.D., et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413 (2001) 848-852
128. Yang F., Yang J., Zhang X., et al. Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res 33 (2005) 6445-6458
129. Jin Q., Yuan Z., Xu J., et al. Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res 30 (2002) 4432-4441
130. Jiang Y., Yang F., Zhang X., et al. The complete sequence and analysis of the large virulence plasmid pSS of Shigella sonnei. Plasmid 54 (2005) 149-159
131. Makino K., Oshima K., Kurokawa K., et al. Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V. cholerae. Lancet 361 (2003) 743-749
132. Thomson N.R., Howard S., Wren B.W., et al. The complete genome sequence and comparative genome analysis of the high pathogenicity Yersinia enterocolitica strain 8081. PLoS Genet 2 (2006) e206